HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology3 papers

Poorly differentiated carcinoma

Last edited: 4/23/2026

Overview

Poorly differentiated carcinoma refers to a highly malignant neoplasm characterized by significant loss of differentiation, aggressive behavior, and widespread visceral organ involvement 1.

Diagnosis

  • Clinical Presentation: Diffuse involvement of visceral organs 1.
  • Imaging: Angiographic findings may mimic vasculitis syndromes, such as polyarteritis nodosa, due to necrotizing vasculitides forming microaneurysms 1.
  • Histopathology: Essential for confirming poorly differentiated features through biopsy and tissue examination 1.

    • Management

  • Surgical Intervention: Primary treatment may involve surgical resection if feasible 1.
  • Systemic Therapy: Chemotherapy regimens tailored to the specific type of carcinoma, though specific drugs and doses are not detailed in the abstract 1.
  • Supportive Care: Management of symptoms and complications, including potential organ dysfunction 1.

    • Special Populations

  • No Specific Data: The provided abstract does not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.

    • Key Recommendations

  • Confirm diagnosis through histopathology and imaging to differentiate from vasculitis syndromes (Evidence: Weak) 1.
  • Consider surgical resection as a primary treatment approach when feasible (Evidence: Weak) 1.
  • Implement systemic chemotherapy based on tumor type, though specific protocols are not detailed here (Evidence: Expert opinion) 1.

    • References

    1 Easterbrook JS. Renal and hepatic microaneurysms: report of a new entity simulating polyarteritis nodosa. Radiology 1980. link

    Original source

    1. [1]
      Renal and hepatic microaneurysms: report of a new entity simulating polyarteritis nodosa. — Easterbrook JS Radiology (1980)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG